Serveur d'exploration sur la rapamycine et les champignons

Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.

Rapamycin destabilizes interleukin-3 mRNA in autocrine tumor cells by a mechanism requiring an intact 3' untranslated region.

Identifieur interne : 001A81 ( Main/Exploration ); précédent : 001A80; suivant : 001A82

Rapamycin destabilizes interleukin-3 mRNA in autocrine tumor cells by a mechanism requiring an intact 3' untranslated region.

Auteurs : R. Banholzer [Suisse] ; A P Nair ; H H Hirsch ; X F Ming ; C. Moroni

Source :

RBID : pubmed:9154824

Descripteurs français

English descriptors

Abstract

We analyzed the effect of rapamycin on autocrine mast cell tumor lines with abnormally stable interleukin-3 (IL-3) transcripts due to a defect in mRNA degradation. Rapamycin inhibited IL-3 mRNA expression specifically, while transcripts of IL-4 and IL-6 were not affected. As indicated by the use of the transcriptional inhibitor actinomycin D or by reporter constructs, inhibition was posttranscriptional and resulted from destabilization of the mRNA. Transcripts from transgenes lacking the AU-rich 3' untranslated region were refractory to drug-induced degradation, suggesting that these 3' sequences contain the target of the rapamycin effect. Rapamycin did not promote IL-3 mRNA degradation in cells of a tumor variant lacking expression of FKBP12, the binding protein of rapamycin. Experiments with wortmannin indicated that rapamycin does not act via p70S6 kinase. FK-506, another ligand of FKBP12 affecting the phosphatase calcineurin, did not antagonize but shared the effect of rapamycin. Our data fit a model whereby both FKBP12 and calcineurin target an unknown regulator of IL-3 mRNA turnover.

DOI: 10.1128/mcb.17.6.3254
PubMed: 9154824
PubMed Central: PMC232178


Affiliations:


Links toward previous steps (curation, corpus...)


Le document en format XML

<record>
<TEI>
<teiHeader>
<fileDesc>
<titleStmt>
<title xml:lang="en">Rapamycin destabilizes interleukin-3 mRNA in autocrine tumor cells by a mechanism requiring an intact 3' untranslated region.</title>
<author>
<name sortKey="Banholzer, R" sort="Banholzer, R" uniqKey="Banholzer R" first="R" last="Banholzer">R. Banholzer</name>
<affiliation wicri:level="1">
<nlm:affiliation>Institute for Medical Microbiology, University of Basel, Switzerland.</nlm:affiliation>
<country xml:lang="fr">Suisse</country>
<wicri:regionArea>Institute for Medical Microbiology, University of Basel</wicri:regionArea>
<wicri:noRegion>University of Basel</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Nair, A P" sort="Nair, A P" uniqKey="Nair A" first="A P" last="Nair">A P Nair</name>
</author>
<author>
<name sortKey="Hirsch, H H" sort="Hirsch, H H" uniqKey="Hirsch H" first="H H" last="Hirsch">H H Hirsch</name>
</author>
<author>
<name sortKey="Ming, X F" sort="Ming, X F" uniqKey="Ming X" first="X F" last="Ming">X F Ming</name>
</author>
<author>
<name sortKey="Moroni, C" sort="Moroni, C" uniqKey="Moroni C" first="C" last="Moroni">C. Moroni</name>
</author>
</titleStmt>
<publicationStmt>
<idno type="wicri:source">PubMed</idno>
<date when="1997">1997</date>
<idno type="RBID">pubmed:9154824</idno>
<idno type="pmid">9154824</idno>
<idno type="pmc">PMC232178</idno>
<idno type="doi">10.1128/mcb.17.6.3254</idno>
<idno type="wicri:Area/Main/Corpus">001A86</idno>
<idno type="wicri:explorRef" wicri:stream="Main" wicri:step="Corpus" wicri:corpus="PubMed">001A86</idno>
<idno type="wicri:Area/Main/Curation">001A86</idno>
<idno type="wicri:explorRef" wicri:stream="Main" wicri:step="Curation">001A86</idno>
<idno type="wicri:Area/Main/Exploration">001A86</idno>
</publicationStmt>
<sourceDesc>
<biblStruct>
<analytic>
<title xml:lang="en">Rapamycin destabilizes interleukin-3 mRNA in autocrine tumor cells by a mechanism requiring an intact 3' untranslated region.</title>
<author>
<name sortKey="Banholzer, R" sort="Banholzer, R" uniqKey="Banholzer R" first="R" last="Banholzer">R. Banholzer</name>
<affiliation wicri:level="1">
<nlm:affiliation>Institute for Medical Microbiology, University of Basel, Switzerland.</nlm:affiliation>
<country xml:lang="fr">Suisse</country>
<wicri:regionArea>Institute for Medical Microbiology, University of Basel</wicri:regionArea>
<wicri:noRegion>University of Basel</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Nair, A P" sort="Nair, A P" uniqKey="Nair A" first="A P" last="Nair">A P Nair</name>
</author>
<author>
<name sortKey="Hirsch, H H" sort="Hirsch, H H" uniqKey="Hirsch H" first="H H" last="Hirsch">H H Hirsch</name>
</author>
<author>
<name sortKey="Ming, X F" sort="Ming, X F" uniqKey="Ming X" first="X F" last="Ming">X F Ming</name>
</author>
<author>
<name sortKey="Moroni, C" sort="Moroni, C" uniqKey="Moroni C" first="C" last="Moroni">C. Moroni</name>
</author>
</analytic>
<series>
<title level="j">Molecular and cellular biology</title>
<idno type="ISSN">0270-7306</idno>
<imprint>
<date when="1997" type="published">1997</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc>
<textClass>
<keywords scheme="KwdEn" xml:lang="en">
<term>Amino Acid Isomerases (metabolism)</term>
<term>Animals (MeSH)</term>
<term>Antibiotics, Antineoplastic (metabolism)</term>
<term>Antibiotics, Antineoplastic (pharmacology)</term>
<term>Binding Sites (MeSH)</term>
<term>Carrier Proteins (metabolism)</term>
<term>Cell Division (drug effects)</term>
<term>Cyclosporine (pharmacology)</term>
<term>DNA-Binding Proteins (metabolism)</term>
<term>Down-Regulation (drug effects)</term>
<term>Heat-Shock Proteins (metabolism)</term>
<term>Immunosuppressive Agents (pharmacology)</term>
<term>Interleukin-3 (genetics)</term>
<term>Mice (MeSH)</term>
<term>Polyenes (metabolism)</term>
<term>Polyenes (pharmacology)</term>
<term>Protein Processing, Post-Translational (MeSH)</term>
<term>Protein-Serine-Threonine Kinases (antagonists & inhibitors)</term>
<term>RNA, Messenger (metabolism)</term>
<term>Ribosomal Protein S6 Kinases (MeSH)</term>
<term>Sirolimus (MeSH)</term>
<term>Tacrolimus (pharmacology)</term>
<term>Tacrolimus Binding Proteins (MeSH)</term>
<term>Tumor Cells, Cultured (MeSH)</term>
</keywords>
<keywords scheme="KwdFr" xml:lang="fr">
<term>ARN messager (métabolisme)</term>
<term>Amino-acid isomerases (métabolisme)</term>
<term>Animaux (MeSH)</term>
<term>Antibiotiques antinéoplasiques (métabolisme)</term>
<term>Antibiotiques antinéoplasiques (pharmacologie)</term>
<term>Cellules cancéreuses en culture (MeSH)</term>
<term>Ciclosporine (pharmacologie)</term>
<term>Division cellulaire (effets des médicaments et des substances chimiques)</term>
<term>Immunosuppresseurs (pharmacologie)</term>
<term>Interleukine-3 (génétique)</term>
<term>Maturation post-traductionnelle des protéines (MeSH)</term>
<term>Polyènes (métabolisme)</term>
<term>Polyènes (pharmacologie)</term>
<term>Protein-Serine-Threonine Kinases (antagonistes et inhibiteurs)</term>
<term>Protéines de liaison au tacrolimus (MeSH)</term>
<term>Protéines de liaison à l'ADN (métabolisme)</term>
<term>Protéines de transport (métabolisme)</term>
<term>Protéines du choc thermique (métabolisme)</term>
<term>Ribosomal Protein S6 Kinases (MeSH)</term>
<term>Régulation négative (effets des médicaments et des substances chimiques)</term>
<term>Sirolimus (MeSH)</term>
<term>Sites de fixation (MeSH)</term>
<term>Souris (MeSH)</term>
<term>Tacrolimus (pharmacologie)</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="antagonists & inhibitors" xml:lang="en">
<term>Protein-Serine-Threonine Kinases</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="genetics" xml:lang="en">
<term>Interleukin-3</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="metabolism" xml:lang="en">
<term>Amino Acid Isomerases</term>
<term>Antibiotics, Antineoplastic</term>
<term>Carrier Proteins</term>
<term>DNA-Binding Proteins</term>
<term>Heat-Shock Proteins</term>
<term>Polyenes</term>
<term>RNA, Messenger</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="pharmacology" xml:lang="en">
<term>Antibiotics, Antineoplastic</term>
<term>Cyclosporine</term>
<term>Immunosuppressive Agents</term>
<term>Polyenes</term>
<term>Tacrolimus</term>
</keywords>
<keywords scheme="MESH" qualifier="antagonistes et inhibiteurs" xml:lang="fr">
<term>Protein-Serine-Threonine Kinases</term>
</keywords>
<keywords scheme="MESH" qualifier="drug effects" xml:lang="en">
<term>Cell Division</term>
<term>Down-Regulation</term>
</keywords>
<keywords scheme="MESH" qualifier="effets des médicaments et des substances chimiques" xml:lang="fr">
<term>Division cellulaire</term>
<term>Régulation négative</term>
</keywords>
<keywords scheme="MESH" qualifier="génétique" xml:lang="fr">
<term>Interleukine-3</term>
</keywords>
<keywords scheme="MESH" qualifier="métabolisme" xml:lang="fr">
<term>ARN messager</term>
<term>Amino-acid isomerases</term>
<term>Antibiotiques antinéoplasiques</term>
<term>Polyènes</term>
<term>Protéines de liaison à l'ADN</term>
<term>Protéines de transport</term>
<term>Protéines du choc thermique</term>
</keywords>
<keywords scheme="MESH" qualifier="pharmacologie" xml:lang="fr">
<term>Antibiotiques antinéoplasiques</term>
<term>Ciclosporine</term>
<term>Immunosuppresseurs</term>
<term>Polyènes</term>
<term>Tacrolimus</term>
</keywords>
<keywords scheme="MESH" xml:lang="en">
<term>Animals</term>
<term>Binding Sites</term>
<term>Mice</term>
<term>Protein Processing, Post-Translational</term>
<term>Ribosomal Protein S6 Kinases</term>
<term>Sirolimus</term>
<term>Tacrolimus Binding Proteins</term>
<term>Tumor Cells, Cultured</term>
</keywords>
<keywords scheme="MESH" xml:lang="fr">
<term>Animaux</term>
<term>Cellules cancéreuses en culture</term>
<term>Maturation post-traductionnelle des protéines</term>
<term>Protéines de liaison au tacrolimus</term>
<term>Ribosomal Protein S6 Kinases</term>
<term>Sirolimus</term>
<term>Sites de fixation</term>
<term>Souris</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front>
<div type="abstract" xml:lang="en">We analyzed the effect of rapamycin on autocrine mast cell tumor lines with abnormally stable interleukin-3 (IL-3) transcripts due to a defect in mRNA degradation. Rapamycin inhibited IL-3 mRNA expression specifically, while transcripts of IL-4 and IL-6 were not affected. As indicated by the use of the transcriptional inhibitor actinomycin D or by reporter constructs, inhibition was posttranscriptional and resulted from destabilization of the mRNA. Transcripts from transgenes lacking the AU-rich 3' untranslated region were refractory to drug-induced degradation, suggesting that these 3' sequences contain the target of the rapamycin effect. Rapamycin did not promote IL-3 mRNA degradation in cells of a tumor variant lacking expression of FKBP12, the binding protein of rapamycin. Experiments with wortmannin indicated that rapamycin does not act via p70S6 kinase. FK-506, another ligand of FKBP12 affecting the phosphatase calcineurin, did not antagonize but shared the effect of rapamycin. Our data fit a model whereby both FKBP12 and calcineurin target an unknown regulator of IL-3 mRNA turnover.</div>
</front>
</TEI>
<pubmed>
<MedlineCitation Status="MEDLINE" Owner="NLM">
<PMID Version="1">9154824</PMID>
<DateCompleted>
<Year>1997</Year>
<Month>06</Month>
<Day>19</Day>
</DateCompleted>
<DateRevised>
<Year>2019</Year>
<Month>05</Month>
<Day>08</Day>
</DateRevised>
<Article PubModel="Print">
<Journal>
<ISSN IssnType="Print">0270-7306</ISSN>
<JournalIssue CitedMedium="Print">
<Volume>17</Volume>
<Issue>6</Issue>
<PubDate>
<Year>1997</Year>
<Month>Jun</Month>
</PubDate>
</JournalIssue>
<Title>Molecular and cellular biology</Title>
<ISOAbbreviation>Mol Cell Biol</ISOAbbreviation>
</Journal>
<ArticleTitle>Rapamycin destabilizes interleukin-3 mRNA in autocrine tumor cells by a mechanism requiring an intact 3' untranslated region.</ArticleTitle>
<Pagination>
<MedlinePgn>3254-60</MedlinePgn>
</Pagination>
<Abstract>
<AbstractText>We analyzed the effect of rapamycin on autocrine mast cell tumor lines with abnormally stable interleukin-3 (IL-3) transcripts due to a defect in mRNA degradation. Rapamycin inhibited IL-3 mRNA expression specifically, while transcripts of IL-4 and IL-6 were not affected. As indicated by the use of the transcriptional inhibitor actinomycin D or by reporter constructs, inhibition was posttranscriptional and resulted from destabilization of the mRNA. Transcripts from transgenes lacking the AU-rich 3' untranslated region were refractory to drug-induced degradation, suggesting that these 3' sequences contain the target of the rapamycin effect. Rapamycin did not promote IL-3 mRNA degradation in cells of a tumor variant lacking expression of FKBP12, the binding protein of rapamycin. Experiments with wortmannin indicated that rapamycin does not act via p70S6 kinase. FK-506, another ligand of FKBP12 affecting the phosphatase calcineurin, did not antagonize but shared the effect of rapamycin. Our data fit a model whereby both FKBP12 and calcineurin target an unknown regulator of IL-3 mRNA turnover.</AbstractText>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Banholzer</LastName>
<ForeName>R</ForeName>
<Initials>R</Initials>
<AffiliationInfo>
<Affiliation>Institute for Medical Microbiology, University of Basel, Switzerland.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Nair</LastName>
<ForeName>A P</ForeName>
<Initials>AP</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Hirsch</LastName>
<ForeName>H H</ForeName>
<Initials>HH</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Ming</LastName>
<ForeName>X F</ForeName>
<Initials>XF</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Moroni</LastName>
<ForeName>C</ForeName>
<Initials>C</Initials>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType UI="D016428">Journal Article</PublicationType>
<PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType>
</PublicationTypeList>
</Article>
<MedlineJournalInfo>
<Country>United States</Country>
<MedlineTA>Mol Cell Biol</MedlineTA>
<NlmUniqueID>8109087</NlmUniqueID>
<ISSNLinking>0270-7306</ISSNLinking>
</MedlineJournalInfo>
<ChemicalList>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D000903">Antibiotics, Antineoplastic</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D002352">Carrier Proteins</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D004268">DNA-Binding Proteins</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D006360">Heat-Shock Proteins</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D007166">Immunosuppressive Agents</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D007377">Interleukin-3</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D011090">Polyenes</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D012333">RNA, Messenger</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>83HN0GTJ6D</RegistryNumber>
<NameOfSubstance UI="D016572">Cyclosporine</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>EC 2.7.11.1</RegistryNumber>
<NameOfSubstance UI="D017346">Protein-Serine-Threonine Kinases</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>EC 2.7.11.1</RegistryNumber>
<NameOfSubstance UI="D019893">Ribosomal Protein S6 Kinases</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>EC 5.1.1.-</RegistryNumber>
<NameOfSubstance UI="D000591">Amino Acid Isomerases</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>EC 5.2.1.-</RegistryNumber>
<NameOfSubstance UI="D022021">Tacrolimus Binding Proteins</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>W36ZG6FT64</RegistryNumber>
<NameOfSubstance UI="D020123">Sirolimus</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>WM0HAQ4WNM</RegistryNumber>
<NameOfSubstance UI="D016559">Tacrolimus</NameOfSubstance>
</Chemical>
</ChemicalList>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList>
<MeshHeading>
<DescriptorName UI="D000591" MajorTopicYN="N">Amino Acid Isomerases</DescriptorName>
<QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D000903" MajorTopicYN="N">Antibiotics, Antineoplastic</DescriptorName>
<QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName>
<QualifierName UI="Q000494" MajorTopicYN="N">pharmacology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D001665" MajorTopicYN="N">Binding Sites</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D002352" MajorTopicYN="N">Carrier Proteins</DescriptorName>
<QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D002455" MajorTopicYN="N">Cell Division</DescriptorName>
<QualifierName UI="Q000187" MajorTopicYN="N">drug effects</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D016572" MajorTopicYN="N">Cyclosporine</DescriptorName>
<QualifierName UI="Q000494" MajorTopicYN="N">pharmacology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D004268" MajorTopicYN="N">DNA-Binding Proteins</DescriptorName>
<QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D015536" MajorTopicYN="N">Down-Regulation</DescriptorName>
<QualifierName UI="Q000187" MajorTopicYN="N">drug effects</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D006360" MajorTopicYN="N">Heat-Shock Proteins</DescriptorName>
<QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D007166" MajorTopicYN="N">Immunosuppressive Agents</DescriptorName>
<QualifierName UI="Q000494" MajorTopicYN="N">pharmacology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D007377" MajorTopicYN="N">Interleukin-3</DescriptorName>
<QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D051379" MajorTopicYN="N">Mice</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D011090" MajorTopicYN="N">Polyenes</DescriptorName>
<QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName>
<QualifierName UI="Q000494" MajorTopicYN="N">pharmacology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D011499" MajorTopicYN="N">Protein Processing, Post-Translational</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D017346" MajorTopicYN="N">Protein-Serine-Threonine Kinases</DescriptorName>
<QualifierName UI="Q000037" MajorTopicYN="N">antagonists & inhibitors</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D012333" MajorTopicYN="N">RNA, Messenger</DescriptorName>
<QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D019893" MajorTopicYN="N">Ribosomal Protein S6 Kinases</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D020123" MajorTopicYN="N">Sirolimus</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D016559" MajorTopicYN="N">Tacrolimus</DescriptorName>
<QualifierName UI="Q000494" MajorTopicYN="N">pharmacology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D022021" MajorTopicYN="N">Tacrolimus Binding Proteins</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D014407" MajorTopicYN="N">Tumor Cells, Cultured</DescriptorName>
</MeshHeading>
</MeshHeadingList>
</MedlineCitation>
<PubmedData>
<History>
<PubMedPubDate PubStatus="pubmed">
<Year>1997</Year>
<Month>6</Month>
<Day>1</Day>
</PubMedPubDate>
<PubMedPubDate PubStatus="medline">
<Year>1997</Year>
<Month>6</Month>
<Day>1</Day>
<Hour>0</Hour>
<Minute>1</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="entrez">
<Year>1997</Year>
<Month>6</Month>
<Day>1</Day>
<Hour>0</Hour>
<Minute>0</Minute>
</PubMedPubDate>
</History>
<PublicationStatus>ppublish</PublicationStatus>
<ArticleIdList>
<ArticleId IdType="pubmed">9154824</ArticleId>
<ArticleId IdType="pmc">PMC232178</ArticleId>
<ArticleId IdType="doi">10.1128/mcb.17.6.3254</ArticleId>
</ArticleIdList>
<ReferenceList>
<Reference>
<Citation>Nature. 1991 Aug 29;352(6338):803-7</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">1715516</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Trends Biochem Sci. 1996 May;21(5):181-5</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">8871403</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Nature. 1986 Feb 20-26;319(6055):640-6</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">3005865</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Nucleic Acids Res. 1987 Jan 12;15(1):333-44</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">3029676</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Immunol. 1988 Jan 1;140(1):131-7</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">2447167</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Eur J Immunol. 1988 Jan;18(1):97-104</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">2831066</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Cell. 1988 Jun 3;53(5):815-25</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">3370673</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Immunol. 1988 Dec 1;141(11):3875-81</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">3263439</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Anal Biochem. 1988 Aug 15;173(1):93-5</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">2461121</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Cell. 1988 Dec 23;55(6):1115-22</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">3060261</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Nature. 1989 May 11;339(6220):150-2</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">2524008</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Mol Cell Biol. 1989 Mar;9(3):1183-90</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">2498644</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>EMBO J. 1989 Dec 1;8(12):3693-9</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">2583116</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Proc Natl Acad Sci U S A. 1989 Dec;86(23):9299-302</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">2512578</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Immunol. 1990 Jan 1;144(1):251-8</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">1688572</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Proc Natl Acad Sci U S A. 1990 Jan;87(2):777-81</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">2105489</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Growth Factors. 1989;1(2):165-77</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">2576219</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Eur J Immunol. 1990 Jan;20(1):163-70</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">1968391</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Proc Natl Acad Sci U S A. 1990 Dec;87(23):9231-5</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">2123553</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Cell. 1991 Aug 23;66(4):807-15</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">1715244</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Gene. 1991 Dec 30;109(2):255-8</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">1722474</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>EMBO J. 1992 May;11(5):1743-9</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">1374712</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Nature. 1992 Jun 25;357(6380):692-4</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">1377361</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Nature. 1992 Jun 25;357(6380):695-7</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">1377362</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Nature. 1992 Jul 2;358(6381):70-3</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">1614535</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Cell. 1992 Jun 26;69(7):1227-36</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">1377606</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Cell. 1992 Aug 7;70(3):365-8</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">1379518</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Science. 1992 Aug 14;257(5072):973-7</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">1380182</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Oncogene. 1992 Oct;7(10):1963-72</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">1408138</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Biol Chem. 1993 Feb 15;268(5):3734-8</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">8429048</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Cell. 1993 May 7;73(3):585-96</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">8387896</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Adv Immunol. 1993;53:1-29</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">8512033</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Exp Med. 1993 Aug 1;178(2):403-11</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">8340751</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Biol Chem. 1993 Oct 25;268(30):22825-9</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">8226793</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Nature. 1994 May 19;369(6477):239-42</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">8183344</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Proc Natl Acad Sci U S A. 1994 May 10;91(10):4441-5</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">8183928</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Nature. 1994 Jun 30;369(6483):756-8</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">8008069</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Cell. 1994 Jul 15;78(1):35-43</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">7518356</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Blood. 1994 Sep 1;84(5):1543-52</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">7520778</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Biol Chem. 1994 Nov 18;269(46):28591-7</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">7961806</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Mol Cell Biol. 1994 Dec;14(12):7984-95</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">7969138</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Proc Natl Acad Sci U S A. 1994 Nov 22;91(24):11477-81</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">7972087</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Nature. 1994 Dec 8;372(6506):570-3</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">7990932</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Mol Cell Biol. 1995 Apr;15(4):2219-30</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">7891716</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Biol Chem. 1995 Aug 4;270(31):18531-8</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">7629182</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Biol Chem. 1995 Sep 1;270(35):20629-35</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">7657642</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Trends Biochem Sci. 1995 Aug;20(8):303-7</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">7667888</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Biol Chem. 1995 Sep 8;270(36):21396-403</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">7545671</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Nature. 1995 Oct 5;377(6548):441-6</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">7566123</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Nature. 1995 Sep 28;377(6547):358-62</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">7566093</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Microbiol Rev. 1995 Sep;59(3):423-50</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">7565413</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Cell. 1995 Nov 3;83(3):463-72</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">8521476</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Trends Biochem Sci. 1995 Nov;20(11):465-70</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">8578590</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>EMBO J. 1996 Feb 1;15(3):658-64</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">8599949</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Curr Opin Cell Biol. 1995 Dec;7(6):806-14</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">8608011</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Proc Natl Acad Sci U S A. 1996 Apr 30;93(9):4076-80</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">8633019</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Cell. 1996 Aug 23;86(4):517-20</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">8752206</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Growth Factors. 1996;13(1-2):99-110</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">8804994</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Eur J Biochem. 1985 Jul 15;150(2):297-304</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">3926497</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
</PubmedData>
</pubmed>
<affiliations>
<list>
<country>
<li>Suisse</li>
</country>
</list>
<tree>
<noCountry>
<name sortKey="Hirsch, H H" sort="Hirsch, H H" uniqKey="Hirsch H" first="H H" last="Hirsch">H H Hirsch</name>
<name sortKey="Ming, X F" sort="Ming, X F" uniqKey="Ming X" first="X F" last="Ming">X F Ming</name>
<name sortKey="Moroni, C" sort="Moroni, C" uniqKey="Moroni C" first="C" last="Moroni">C. Moroni</name>
<name sortKey="Nair, A P" sort="Nair, A P" uniqKey="Nair A" first="A P" last="Nair">A P Nair</name>
</noCountry>
<country name="Suisse">
<noRegion>
<name sortKey="Banholzer, R" sort="Banholzer, R" uniqKey="Banholzer R" first="R" last="Banholzer">R. Banholzer</name>
</noRegion>
</country>
</tree>
</affiliations>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Bois/explor/RapamycinFungusV1/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 001A81 | SxmlIndent | more

Ou

HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 001A81 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Bois
   |area=    RapamycinFungusV1
   |flux=    Main
   |étape=   Exploration
   |type=    RBID
   |clé=     pubmed:9154824
   |texte=   Rapamycin destabilizes interleukin-3 mRNA in autocrine tumor cells by a mechanism requiring an intact 3' untranslated region.
}}

Pour générer des pages wiki

HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/RBID.i   -Sk "pubmed:9154824" \
       | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd   \
       | NlmPubMed2Wicri -a RapamycinFungusV1 

Wicri

This area was generated with Dilib version V0.6.38.
Data generation: Thu Nov 19 21:55:41 2020. Site generation: Thu Nov 19 22:00:39 2020